Becton Dickinson (BDX) Total Liabilities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Total Liabilities came in at $26.3 billion in Q2 2026, down 10.58% year-over-year from $29.4 billion in Q2 2025, and down 1.44% quarter-over-quarter from $26.7 billion in Q1 2026.
Analysis
Becton Dickinson (BDX) Total Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Total Liabilities for 18 consecutive years, with $26.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities fell 10.58% year-over-year to $26.3 billion in Q2 2026; TTM through Jun 2026 was $26.3 billion, a 10.58% decrease from a year earlier, with the FY2025 full-year figure at $29.9 billion, down 4.65% from the prior year.
- Total Liabilities was $26.3 billion for Q2 2026 at Becton Dickinson, down from $26.7 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $31.4 billion in Q3 2024 and troughed at $26.3 billion in Q2 2026.
- A 5-year average of $28.5 billion and a median of $28.6 billion in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities climbed 16.35% in 2024 and retreated 10.58% in 2026, its largest moves.
- Over 5 years, Total Liabilities stood at $27.7 billion in 2022, then fell by 2.59% to $26.9 billion in 2023, then advanced by 9.35% to $29.5 billion in 2024, then advanced by 0.34% to $29.6 billion in 2025, then declined by 10.97% to $26.3 billion in 2026.
- The last three Total Liabilities figures came in at $26.3 billion (Q2 2026), $26.7 billion (Q1 2026), and $29.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 26.32 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 20.27 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 1.09 Bn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 13.61 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 1.24 Bn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 79.34 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 21.44 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 68.83 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 4.69 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | 3.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.32 Bn |
| Mar 31, 2026 | 26.70 Bn |
| Dec 31, 2025 | 29.56 Bn |
| Sep 30, 2025 | 29.94 Bn |
| Jun 30, 2025 | 29.43 Bn |
| Mar 31, 2025 | 29.23 Bn |
| Dec 31, 2024 | 29.46 Bn |
| Sep 30, 2024 | 31.40 Bn |
| Jun 30, 2024 | 29.71 Bn |
| Mar 31, 2024 | 28.51 Bn |
| Dec 31, 2023 | 26.94 Bn |
| Sep 30, 2023 | 26.98 Bn |
| Jun 30, 2023 | 27.08 Bn |
| Mar 31, 2023 | 28.71 Bn |
| Dec 31, 2022 | 27.66 Bn |
| Sep 30, 2022 | 27.65 Bn |
| Jun 30, 2022 | 27.71 Bn |
| Mar 31, 2022 | 30.26 Bn |
| Dec 31, 2021 | 29.20 Bn |
| Sep 30, 2021 | 30.19 Bn |